Quantitative analysis for Tenax Therapeutics, Inc. (TENX) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Unrated (50.0). 32 signals analyzed (27 differentiated alt-data).
TENX stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-04-29 | $14.60 | $12.67 | $12.78 |
| 2026-05-11 | $12.32 | $11.55 | $11.95 |
| 2026-05-21 | $12.75 | $11.85 | $12.36 |
| 2026-06-03 | $11.34 | $10.76 | $10.77 |
| 2026-06-15 | $11.74 | $11.11 | $11.55 |
| 2026-06-26 | $13.87 | $12.83 | $13.44 |
| 2026-07-09 | $19.40 | $17.73 | $18.32 |
| 2026-07-21 | $16.25 | $15.43 | $15.72 |
| 2026-07-31 | $15.51 | $13.65 | $13.70 |
| 2026-08-12 | $1.75 | $1.58 | $1.72 |
| 2026-08-24 | $1.90 | $1.69 | $1.85 |
| 2026-09-03 | $2.04 | $1.77 | $1.78 |
How Tenax Therapeutics, Inc. stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| BDTX | Black Diamond Therapeutics, Inc. | $206M | — |
| INFU | InfuSystem Holdings, Inc. | $205M | — |
| CNTX | Context Therapeutics Inc. | $205M | — |
| WHWK | Whitehawk Therapeutics Inc | $209M | — |
View all Health Care stocks by valuation and signals →
Tenax Therapeutics, Inc. (TENX) scores Unrated (50.0), and the composite conceals a 66-point disagreement between its dimensions. It is strongest on analyst consensus at 67, and weakest on competitive moat at 1. A stock can carry analyst consensus that high while competitive moat sits at 1; the composite averages that tension away, which is why the breakdown is worth reading before the headline number. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| analyst consensus | 67 |
| technicals | 49 |
| competitive moat | 1 |
StoQuant analyzes 32 signals (27 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on Tenax Therapeutics, Inc. (TENX): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/TENX"><img src="https://stoquant.com/badge/TENX.svg" alt="Tenax Therapeutics, Inc. (TENX) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Weekly Q-Score signals and insider buying activity on our highest-conviction stock picks. Email only, no account needed. See a sample digest.